Milestones, Partnerships, Awards
Milestones
2025 |
| ibidi is significantly expanding its Multiwell Plate Product Family and now offers µ-Plates 6, 24, 96, and 384 Well with #1.5 H Glass and #1.5 Polymer coverslips for cell culture and high-throughput imaging. |
2024 |
| After the huge success of the 1st International Flow Meeting in Munich in 2020 with more than 100 participants from all over the world, ibidi is hosting the 2nd International Flow Meeting in Chicago, USA. |
2023 |
| ibidi goes 3D: 3D cell cultures, such as spheroids, organoids, or cells in 3D scaffolds, are increasingly adopted for in vitro studies, delivering a more precise representation of the in vivo environment compared to traditional 2D cultures. With innovative µ-Slides, such as the µ-Slide Spheroid Perfusion and the µ-Slide I Luer 3D, ibidi offers advanced solutions for 3D cell culture experiments in static or flow conditions. |
2022 | Launch of the annual ibidi Paper Award—a prize that recognizes early career scientists for their outstanding first or last author publications in a specific research field. This year, two postdocs and one PhD student received the ibidi Paper Award—along with 500€ each—for their scientific contributions in cancer research. | |
2021 | ibidi is celebrating 20 Years of Innovation with a special anniversary website and giveaway. | |
2020 | ibidi announces the launch of the ibidi µ-Patterning technology, which enables spatially defined cell adhesion for 2D and 3D cell culture applications. | |
2019 | ibidi moves to its own premises. The new building offers a lot more space for offices, labs, and production facilities. | |
2018 | The ibidi µ-Dish 35 mm, high Bioinert provides a completely new solution for all scientists who want to combine long-term culture with the high-resolution microscopy of living spheroids or suspension cells on a non-adherent surface. | |
2016 | ibidi expands the Removable Chambers family and also launches the µ-Slide III 3D Perfusion, a µ-Slide suitable for the long-term cultivation and perfusion of cells or tissue samples in 3D matrices. | |
2015 | The US headquarters, ibidi USA, Inc., is founded in Madison, Wisconsin. | |
2010 | With LifeAct, ibidi releases a rapid, non-invasive and non-toxic solution for the visualization of filamentous actin (F-actin) in living and fixed eukaryotic cells. | |
2008 | ibidi launches the Culture-Insert for wound healing and migration assays and the µ-Slide Angiogenesis for tube formation assays. | |
2007 | ibidi releases a new µ-Slide Chemotaxis for the optical analysis of fast or slow migrating adherent cells and non-adherent cells in 2D or 3D gel matrices. | |
2006 | ibidi introduces the ibidi Pump System, an important tool for cancer and atherosclerosis research, and designed for the cultivation of endothelial cells under perfusion. | |
2004 | ibidi releases the µ-Slide family, which is based on the µ-Slide I technology. The different µ-Slide designs are optimized for specific cell-based applications. | |
2002 | As their first product, ibidi launches the µ-Slide I, a novel invention that allows for both cell culturing and high-resolution microscopy on a single slide. The high optical quality of the µ–Slide I can be utilized for cell-based assays in research and high throughput applications. | |
2001 | ibidi was founded by four scientists as a spin-off from the Technical University Munich (TUM) and the Center of Nanoscience (CeNS) at the University of Munich (LMU). |
Selected Partnerships
Selected Academic and Industrial Partnerships Funded by the EU, the State of Germany, and the State of Bavaria
Right from the start, ibidi has been developing its products in close collaboration with scientists in both academia and life science companies, ensuring the effective application of all ibidi products in the lab. Today, these international academic and industrial partnerships help ibidi work to overcome the substantial challenges of the fast-developing field of cell research. The EU, the German state, and the Federal State of Bavaria fund several of these joint research projects that mainly deal with research on cell-based assays, and the corresponding technical equipment (e.g., perfusion and incubation systems).
| Bavarian Funding
|
|
|
|
|
|
|
Are you interested in a joint research project with ibidi?
Please contact us at: info@ibidi.com
Selected Awards
|
| ibidi has been honored as one of Bavaria’s 50 fastest-growing companies in 2025. The “BAYERNS BEST 50” award, presented by the Bavarian State Ministry of Economic Affairs, Regional Development, and Energy, recognizes mid-sized companies that have achieved exceptional growth in both revenue and employee numbers over the past 5 years. |
|
| ibidi ranks among Bavaria’s 20 most family-friendly companies. In 2025, the Minister of Economic Affairs and the Minister of Labor honor ibidi’s exemplary family policy. |
| For being at the forefront of providing oncology solutions and impacting the marketplace, ibidi has been recognized as one of the "Top 10 Oncology Solution Companies in Europe 2023". | |
| ibidi receives the German bAV Award 2023. With this award, the insurance and finance industry honors ibidi’s innovative concept of company pension plans. | |
|
| |
| ibidi has been recognized as one of the "Top 10 Virology Solution Companies in Europe 2021". | |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
